PharmTech AI Pulse Check panelists explain why attribution, audit trails, and sign-off matter more than AI watermark detection for GxP quality teams.
|Articles|March 2, 2020
- Pharmaceutical Technology-03-02-2020
- Volume 44
- Issue 3
Double Clamshell Barrel Continuous Processor
Readco Kurimoto introduced a continuous processor with a double clamshell barrel design that provides full access to the paddle and screw assembly to enable thorough cleaning and inspection processes while allowing for easy adjustments to the configuration.
Readco Kurimoto introduced a continuous processor with a double clamshell barrel design that provides full access to the paddle and screw assembly to enable thorough cleaning and inspection processes while allowing for easy adjustments to the configuration.
The barrel top and bottom of the processor can be easily opened and closed with the push of a button, and the barrel is automatically locked in the open position for cleaning and maintenance, which eliminates the need for the cranes and hoists traditionally used to maintain the barrel. Additionally, the clamshell design reduces the potential of cross-contamination and offers flexible options for processors interested in constructing multiple product formulations with powders, liquids, and viscous materials on a single unit.
Articles in this issue
over 6 years ago
Drug Production Draws Multiple Contendersover 6 years ago
Coronavirus Response: Reaction or New Reality?over 6 years ago
Embracing Change Managementover 6 years ago
Double Planetary Mixerover 6 years ago
Isolator Head for Microbial Air Samplingover 6 years ago
Compressor-Free Plate Sealerover 6 years ago
Challenges in Clinical Manufacturing for Topical Drugsover 6 years ago
Stability Testing: The Crucial Development Stepover 6 years ago
Keeping Toxicity to a Minimumover 6 years ago
Noteworthy Historical Cases of Adverse Drug ReactionsRelated to this article
Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
The FDA approves oral pritelivir for drug-resistant herpes sores in immunocompromised patients; what it means for antiviral development and manufacturing.
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Richard Jaenisch examines whether FDA's NAM pathway truly shortens drug pipelines or just shifts the evidentiary burden elsewhere.
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.